201 related articles for article (PubMed ID: 26188667)
1. Myasthenia gravis exacerbation with low dose ocular botulinum toxin for epiphoria.
Watts J; Brew B; Tisch S
J Clin Neurosci; 2015 Dec; 22(12):1979-81. PubMed ID: 26188667
[TBL] [Abstract][Full Text] [Related]
2. Systemic effect of local and small-dose botulinum toxin injection to unmask subclinical myasthenia gravis.
Iwase T; Iwase C
Graefes Arch Clin Exp Ophthalmol; 2006 Mar; 244(3):415-6. PubMed ID: 16175373
[No Abstract] [Full Text] [Related]
3. Results of lacrimal gland botulinum toxin injection for epiphora in lacrimal obstruction and gustatory tearing.
Wojno TH
Ophthalmic Plast Reconstr Surg; 2011; 27(2):119-21. PubMed ID: 21224749
[TBL] [Abstract][Full Text] [Related]
4. Myaesthenia gravis exacerbation caused by axillary injection of botulinum toxin A for treatment of hyperhidrosis.
El-Heis S; Burke G; Gibb W; Ardern-Jones MR
Clin Exp Dermatol; 2017 Apr; 42(3):357-359. PubMed ID: 28111784
[No Abstract] [Full Text] [Related]
5. Is myasthenia gravis a contraindication for botulinum toxin?
Ma Q; Ran H; Ou C; Liu X; Lu Y; Huang H; Yang W; Yu L; Chen P; Huang X; Qiu L; Lin Z; Huang Z; Liu W
J Clin Neurosci; 2022 Jan; 95():44-47. PubMed ID: 34929650
[TBL] [Abstract][Full Text] [Related]
6. Long term efficacy and safety of botulinum toxin A injection for crocodile tears syndrome.
Barañano DE; Miller NR
Br J Ophthalmol; 2004 Apr; 88(4):588-9. PubMed ID: 15031188
[No Abstract] [Full Text] [Related]
7. Botulinum toxin-B injection into the lacrimal gland and posterior cricoarytenoid muscle for the treatment of epiphora and abductor spasmodic dysphonia secondary to Parkinson's disease.
Sachdev A; Costello D; Madge S
Orbit; 2019 Jun; 38(3):248-251. PubMed ID: 29939826
[TBL] [Abstract][Full Text] [Related]
8. Duration of botulinum toxin effect in the treatment of crocodile tears.
Nava-Castañeda A; Tovilla-Canales JL; Boullosa V; Tovilla-y-Pomar JL; Monroy-Serrano MH; Tapia-Guerra V; Garfias Y
Ophthalmic Plast Reconstr Surg; 2006; 22(6):453-6. PubMed ID: 17117101
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin injection for facial wrinkles.
Small R
Am Fam Physician; 2014 Aug; 90(3):168-75. PubMed ID: 25077722
[TBL] [Abstract][Full Text] [Related]
10. Cosmetic botox injection mimicking myasthenia gravis.
Sunness JS; Kelman S
Plast Reconstr Surg; 2004 Apr; 113(5):1515. PubMed ID: 15060378
[No Abstract] [Full Text] [Related]
11. Progressive cervical kyphosis associated with botulinum toxin injection.
Hogan KA; Manning EL; Glaser JA
South Med J; 2006 Aug; 99(8):888-91. PubMed ID: 16929888
[TBL] [Abstract][Full Text] [Related]
12. A review on use of botulinum toxin for intractable lacrimal drainage disorders.
Singh S; Ali MJ; Paulsen F
Int Ophthalmol; 2018 Oct; 38(5):2233-2238. PubMed ID: 28766277
[TBL] [Abstract][Full Text] [Related]
13. Muscle paralysis produced by botulinum toxin type A injection in treated torticollis patients compared with toxin naive individuals.
Sloop RR; Cole D; Patel MC
Mov Disord; 2001 Jan; 16(1):100-5. PubMed ID: 11215566
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin for palliative treatment of epiphora in a patient with canalicular obstruction.
Tu AH; Chang EL
Ophthalmology; 2005 Aug; 112(8):1469-71. PubMed ID: 15953639
[TBL] [Abstract][Full Text] [Related]
15. Adverse events after botulinum A toxin injection for neurogenic voiding disorders.
De Laet K; Wyndaele JJ
Spinal Cord; 2005 Jul; 43(7):397-9. PubMed ID: 15741978
[TBL] [Abstract][Full Text] [Related]
16. Variable ptosis after botulinum toxin type a injection with positive ice test mimicking ocular myasthenia gravis.
Alaraj AM; Oystreck DT; Bosley TM
J Neuroophthalmol; 2013 Jun; 33(2):169-71. PubMed ID: 23681240
[TBL] [Abstract][Full Text] [Related]
17. Bilateral herpes simplex keratitis reactivation after lacrimal gland botulinum toxin injection.
Narang P; Singh S; Mittal V
Indian J Ophthalmol; 2018 May; 66(5):697-699. PubMed ID: 29676321
[TBL] [Abstract][Full Text] [Related]
18. Sixth nerve palsy following botulinum toxin injection for facial rejuvenation.
Dolar Bilge A; Sadigov F; Salar-Gomceli S
Cutan Ocul Toxicol; 2017 Jun; 36(2):193-194. PubMed ID: 27558865
[TBL] [Abstract][Full Text] [Related]
19. Administration of botulinum toxin.
American Society of Plastic Surgeons, Executive Committee
Plast Reconstr Surg; 2003 Oct; 112(5 Suppl):4S-5S. PubMed ID: 14510021
[No Abstract] [Full Text] [Related]
20. [Management of upper eyelid retraction associated with dysthyroid orbitopathy during the acute inflammatory phase with botulinum toxin type A].
Nava Castañeda A; Tovilla Canales JL; Garnica Hayashi L; Velasco Y Levy A
J Fr Ophtalmol; 2017 Apr; 40(4):279-284. PubMed ID: 28336282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
